HALEON financials Haleon Pakistan Limited
Haleon Pakistan Limited (HALEON) has 5 financial years on file, from the year to 31 Dec 2021. The latest, the year to 31 Dec 2025 earned Rs 54.45 a share on sales of Rs 43.1 bn. 5 quarters are listed below the years.
Results by financial year
Company accounts as filed. Earnings per share are on today’s share count where a split or bonus issue came later. Years to 31 December. 4 of the last 5 years and 5 of the last 8 quarters.
Earnings per share by financial year
| Year | Earnings per share (Rs) | Sales | Gross margin | Net profit as a share of sales | Change in earnings per share on the year before |
|---|---|---|---|---|---|
| Year to 31 Dec 2025 | 54.45 | Rs 43.1 bn | 39.1% | 14.8% | +39.2% |
| Year to 31 Dec 2024 | 39.11 | Rs 37.2 bn | 34.5% | 12.3% | +359.6% |
| Year to 31 Dec 2023 | 8.51 | Rs 31.6 bn | 20.4% | 3.2% | +206.1% |
| Year to 31 Dec 2022 | 2.78 | Rs 27.5 bn | 17.4% | 1.2% | — |
Results by quarter
5 of the last 8 quarters. The fourth quarter is filed only inside the annual accounts.
| Quarter | Earnings per share (Rs) | Sales | Profit after tax | Net profit as a share of sales | Change on the same quarter a year before |
|---|---|---|---|---|---|
| Quarter to 30 Sep 2026 | 13.05 | Rs 10.0 bn | Rs 1.5 bn | 15.3% | -5.4% |
| Quarter to 30 Jun 2026 | 14.32 | Rs 10.1 bn | Rs 1.7 bn | 16.6% | +3.2% |
| Quarter to 31 Mar 2026 | 13.03 | Rs 9.6 bn | Rs 1.5 bn | 15.9% | — |
| Quarter to 30 Sep 2025 | 13.80 | Rs 10.6 bn | Rs 1.6 bn | 15.3% | — |
| Quarter to 30 Jun 2025 | 13.87 | Rs 11.6 bn | Rs 1.6 bn | 14.0% | — |
Annual report figures: income and balance sheet
From each annual report. A blank is a line this page does not show for that year.
| Year | Revenue | Gross profit | Profit after tax | Total assets | Equity | Liabilities | Return on equity | Current ratio | Basis |
|---|---|---|---|---|---|---|---|---|---|
| Year to 31 Dec 2025 | Rs 43.1 bn | — | — | Rs 27.2 bn | Rs 14.8 bn | Rs 12.4 bn | — | 1.57 | unknown |
| Year to 31 Dec 2024 | Rs 37.2 bn | — | — | Rs 21.8 bn | Rs 12.0 bn | Rs 9.8 bn | — | 1.54 | unknown |
| Year to 31 Dec 2023 | Rs 31.6 bn | Rs 6.4 bn | Rs 995.6 m | Rs 18.2 bn | Rs 8.0 bn | Rs 10.2 bn | 12.4% | 1.32 | unknown |
| Year to 31 Dec 2022 | Rs 27.5 bn | Rs 4.8 bn | Rs 325.4 m | Rs 15.1 bn | Rs 7.0 bn | Rs 8.0 bn | 4.6% | 1.42 | unknown |
| Year to 31 Dec 2021 | Rs 24.2 bn | Rs 6.7 bn | Rs 2.1 bn | Rs 13.9 bn | Rs 6.7 bn | Rs 7.2 bn | 31.8% | 1.46 | unknown |
Source: annual report, page 41.
Ratios from the latest annual report
- Book value a share
- Rs 126.41
- Price to book value
- 5.51 times
- Current ratio
- 1.57
- Debt to equity
- 0.84
- Equity as a share of assets
- 54.5%
As of 31 Dec 2025.
Cash flow
Where the cash came from and went
| Profit after tax | Rs 6.4 bn |
| Operating cash flow | Rs 5.6 bn |
| Dividends paid | Rs -3.5 bn |
| Change in cash | Rs 378.6 m |
| Cash at the start of the year | Rs 6.8 bn |
| Cash at the end of the year | Rs 7.2 bn |
Accounts, year to 31 Dec 2025 · filed annual report, page 41The report does not say whether these are group accounts or the company’s own.
Debt
Borrowings and cash
Interest covered by operating profit: Rs 10.7 bn against Rs 22.4 m, 477.1 times
Accounts, year to 31 Dec 2025 · filed annual report, page 41The report does not say whether these are group accounts or the company’s own.
More on HALEON
- HALEON share price and overview
- HALEON dividend history
- Pharmaceuticals sector
- HINOON financials · Highnoon Laboratories Limited
- HPL financials · Hoechst Pakistan Limited
- IBLHL financials · IBL HealthCare Limited
- GLAXO financials · GlaxoSmithKline Pakistan Limited
- ABOT financials · Abbott Laboratories (Pakistan) Limited
- SEARL financials · The Searle Company Limited
Data from PSX via SuperX, delayed and provided for information only — not investment advice. Figures may contain errors; verify with your broker before acting. As of .